ARCHIVES

Clearinghouse Agrees On Three Big New Carcinogens

This article is from The Cancer Letter archive.

Vol. 05 No. 18 | May 4, 1979

Download PDF Visit The Full Archive

Related Articles

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

SBIR Solicitation Issued

September 13, 1996

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

NCI Considering Proposal To Form “Drug Discovery Cooperative Groups”; Concept To DCT Board In June

February 26, 1982

Appreciation: Quack-Buster Saul Green Used Science to Debunk Alternative Medicine Claims.

July 13, 2007